Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
AMES National
ATLO
$280M
| $1.18M | ﹤0.01% |
55,184
-3,800
| -6% | -$69.5K |
|
2302
Network-1 Technologies
NTIP
$35.4M
| $1.18M | ﹤0.01% |
539,593
-2,551
| -0.5% | -$5.58K |
|
|
EVBG
2303
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $1.17M | ﹤0.01% |
48,300
-41,900
| -46% | -$903K |
|
2304
iShares US Equity Factor ETF
LRGF
$3.74B
| $1.17M | ﹤0.01% |
24,300
+14,000
| +136% | +$631K |
|
2305
Precigen
PGEN
$2.18B
| $1.17M | ﹤0.01% |
874,303
-442,987
| -34% | -$520K |
|
2306
Flanigan's Enterprises
BDL
$90.1M
| $1.17M | ﹤0.01% |
45,399
-2,400
| -5% | -$65.9K |
|
2307
IRIDEX
IRIX
$14.9M
| $1.17M | ﹤0.01% |
415,060
+2,000
| +0.5% | +$5.25K |
|
2308
Direxion Daily TSLA Bull 2X ETF
TSLL
$3.54B
| $1.16M | ﹤0.01% |
+80,900
| New | +$1.13M |
|
2309
Zedge
ZDGE
$38.4M
| $1.16M | ﹤0.01% |
492,214
+44,800
| +10% | +$89.8K |
|
|
AHT
2310
Ashford Hospitality Trust
AHT
$20.8M
| $1.15M | ﹤0.01% |
59,474
+20,084
| +51% | +$442K |
|
2311
Vanguard Communication Services ETF
VOX
$5.9B
| $1.15M | ﹤0.01% |
9,800
+7,716
| +370% | +$852K |
|
2312
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.61B
| $1.15M | ﹤0.01% |
20,736
+3,637
| +21% | +$195K |
|
2313
Curis
CRIS
$3.76M
| $1.15M | ﹤0.01% |
4,508
+230
| +5% | +$36.7K |
|
2314
ePlus
PLUS
$2.31B
| $1.15M | ﹤0.01% |
14,400
-2,700
| -16% | -$180K |
|
2315
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.9B
| $1.15M | ﹤0.01% |
19,400
+7,454
| +62% | +$409K |
|
2316
Aware
AWRE
$26.4M
| $1.15M | ﹤0.01% |
690,732
+25,882
| +4% | +$38.8K |
|
2317
Bunge Global
BG
$21.8B
| $1.15M | ﹤0.01% |
+11,353
| New | +$1.19M |
|
2318
Seres Therapeutics
MCRB
$45.6M
| $1.14M | ﹤0.01% |
+40,850
| New | +$1.07M |
|
2319
BK Technologies
BKTI
$277M
| $1.14M | ﹤0.01% |
93,470
-6,012
| -6% | -$77.7K |
|
|
KRON
2320
DELISTED
Kronos Bio
KRON
| $1.14M | ﹤0.01% |
912,926
-88,774
| -9% | -$98.2K |
|
2321
Evolv Technologies
EVLV
$1.05B
| $1.14M | ﹤0.01% |
241,500
+72,229
| +43% | +$309K |
|
|
GBIO
2322
DELISTED
Generation Bio
GBIO
| $1.14M | ﹤0.01% |
68,940
+37,460
| +119% | +$653K |
|
2323
Live Ventures
LIVE
$31.9M
| $1.14M | ﹤0.01% |
44,699
-800
| -2% | -$21.1K |
|
2324
Newmark Group
NMRK
$2.76B
| $1.13M | ﹤0.01% |
+103,345
| New | +$781K |
|
2325
State Street SPDR S&P Global Natural Resources ETF
GNR
$4.93B
| $1.13M | ﹤0.01% |
+19,980
| New | +$1.1M |
|
Similar funds
Jim Simons's Q4 2023 Portfolio in Review
As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Jim Simons opened 702 new positions and closed 633 in Q4 2023.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.